Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Spotify
SPOT
|
+$189M |
| 2 |
Boeing
BA
|
+$57.2M |
| 3 |
Carvana
CVNA
|
+$23.2M |
| 4 |
ConocoPhillips
COP
|
+$22.6M |
| 5 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$19.6M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$500M |
| 2 |
Microsoft
MSFT
|
+$426M |
| 3 |
Amazon
AMZN
|
+$245M |
| 4 |
Meta Platforms (Facebook)
META
|
+$194M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$167M |
Sector Composition
| 1 | Technology | 33.9% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Healthcare | 10.7% |
| 4 | Communication Services | 9.68% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGAU
1751
Centerra Gold
CGAU
$1.86B
| $2.39M | ﹤0.01% |
420,200
-1,500
| -0.4% | -$8.53K |
|
1752
Safety Insurance
SAFT
$1.12B
| $2.39M | ﹤0.01% |
29,000
| – | – |
|
1753
Perella Weinberg Partners
PWP
$1.45B
| $2.38M | ﹤0.01% |
100,000
+900
| +0.9% | +$21.5K |
|
1754
Tilray
TLRY
$1.16B
| $2.36M | ﹤0.01% |
1,776,638
+164,600
| +10% | +$219K |
|
1755
Camping World
CWH
$1.1B
| $2.35M | ﹤0.01% |
111,700
+28,200
| +34% | +$594K |
|
1756
Ardelyx
ARDX
$1.61B
| $2.35M | ﹤0.01% |
463,100
+4,800
| +1% | +$24.3K |
|
1757
Kodiak Gas Services
KGS
$2.92B
| $2.35M | ﹤0.01% |
57,500
+8,100
| +16% | +$331K |
|
1758
Delek US
DK
$1.72B
| $2.35M | ﹤0.01% |
126,891
+1,600
| +1% | +$29.6K |
|
1759
Certara
CERT
$1.75B
| $2.35M | ﹤0.01% |
220,400
| – | – |
|
1760
German American Bancorp
GABC
$1.54B
| $2.35M | ﹤0.01% |
58,350
| – | – |
|
1761
Tronox
TROX
$793M
| $2.33M | ﹤0.01% |
231,800
| – | – |
|
1762
MoonLake Immunotherapeutics
MLTX
$3.45B
| $2.33M | ﹤0.01% |
43,000
| – | – |
|
1763
Blue Bird Corp
BLBD
$1.85B
| $2.33M | ﹤0.01% |
60,200
| – | – |
|
1764
Winmark
WINA
$1.82B
| $2.32M | ﹤0.01% |
5,900
+100
| +2% | +$39.3K |
|
1765
Cimpress
CMPR
$1.5B
| $2.32M | ﹤0.01% |
32,300
| – | – |
|
1766
Weis Markets
WMK
$1.77B
| $2.32M | ﹤0.01% |
34,200
| – | – |
|
1767
Pitney Bowes
PBI
$1.97B
| $2.3M | ﹤0.01% |
317,800
+3,600
| +1% | +$26.1K |
|
1768
InMode
INMD
$970M
| $2.29M | ﹤0.01% |
137,300
-12,300
| -8% | -$205K |
|
1769
Oxford Industries
OXM
$770M
| $2.29M | ﹤0.01% |
29,100
| – | – |
|
|
EVRI
1770
DELISTED
Everi Holdings
EVRI
| $2.29M | ﹤0.01% |
169,200
+4,400
| +3% | +$59.4K |
|
1771
CG Oncology
CGON
$2.53B
| $2.28M | ﹤0.01% |
79,600
+47,000
| +144% | +$1.35M |
|
1772
RxSight
RXST
$385M
| $2.28M | ﹤0.01% |
66,300
+1,700
| +3% | +$58.4K |
|
|
AIV
1773
Aimco
AIV
$1.08B
| $2.28M | ﹤0.01% |
250,684
-5,700
| -2% | -$51.8K |
|
1774
Novavax
NVAX
$1.34B
| $2.28M | ﹤0.01% |
283,400
+35,600
| +14% | +$286K |
|
|
GOGL
1775
DELISTED
Golden Ocean Group
GOGL
| $2.26M | ﹤0.01% |
257,524
+1,658
| +0.6% | +$14.5K |
|